NCT05322330
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Explore clinical trials studying Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma trial results
Active, Not Recruiting
Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT05618327
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China